triazoles has been researched along with Carcinoma in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (7.84) | 18.7374 |
1990's | 2 (3.92) | 18.2507 |
2000's | 21 (41.18) | 29.6817 |
2010's | 23 (45.10) | 24.3611 |
2020's | 1 (1.96) | 2.80 |
Authors | Studies |
---|---|
Abid, S; Ayed-Boussema, I; Azzebi, A; Hamdi, H; Rjiba-Touati, K | 1 |
Banerjee, S; Della Pepa, C; George, A; Gore, M; Kaye, S; McLachlan, J; Migali, C; Tunariu, N | 1 |
Busson, P; Guo, X; Ke, L; Khabir, A; Kieff, E; Ling, Y; Tsao, GS; Wang, C; Xiang, Y; Xiong, G; Zeng, M; Zeng, Y; Zhao, B; Zhou, H | 1 |
El-Baradie, KY; El-Sayed, YS; Fahmy, RM; Gaber, M | 1 |
Bei, JX; Chen, LZ; Feng, QS; Liang, Y; Min, P; Wang, GF; Wang, HB; Wu, MS; Wu, MY; Yang, D; Zeng, YX; Zhao, ZQ | 1 |
Ganjekar, S; Kilara, N; Mahendra, JV; Manjunatha, N; Srinivasa, R | 1 |
Osborne, CK; Rimawi, MF; Schiff, R | 1 |
Beedle, AM; Hanold, LE; Kannan, N; Kennedy, EJ; Oruganty, K; Ton, NT | 1 |
Cai, MC; Di, W; Gao, WQ; Gu, Z; Ji, ZL; Jing, Y; Ma, P; Peng, H; Yan, Y; Zhang, M; Zhang, S; Zhang, Z; Zhuang, G | 1 |
Baldan, F; Conzatti, K; Damante, G; Di Cristofano, A; Di Loreto, C; Durante, C; Filetti, S; Lavarone, E; Mio, C; Orlacchio, A; Puppin, C; Russo, D; Toffoletto, B | 1 |
Niraula, S; Ocana, A | 1 |
Billig, H; Bootz, F; Brägelmann, J; Brossart, P; Kirfel, J; Kristiansen, G; Perner, S; Queisser, A; Schröck, A; Thewes, B; Vogel, W; von Mässenhausen, A | 1 |
Bagnardi, V; Balduzzi, A; Bertolini, F; Cardillo, A; Colleoni, M; Goldhirsch, A; Mancuso, P; Montagna, E; Orlando, L; Scarano, E; Torrisi, R; Veronesi, P; Viale, G | 1 |
Barker, LC; Brand, IR; Crawford, SM | 1 |
de Melo, SJ; do Nascimento, SC; dos Anjos, JV; Neves Filho, RA; Sinou, D; Srivastava, RM | 1 |
Mazur, L; Mendyk, E; Pachuta-Stec, A; Pitucha, M; Rzaczyńska, Z; Rzymowska, J | 1 |
Liang, XW; Lin, SL; Qiao, J; Schatten, H; Sun, QY; Wang, ZB; Wang, ZY; Yan, LY | 1 |
Dieras, V; Florance, A; Gomez, HL; Johnston, S; Kennedy, MJ; Lichinitser, M; Maltzman, J; Manikhas, A; O'Rourke, L; Oliva, C; Pegram, M; Pippen, J; Pivot, X; Press, MF; Romieu, G; Sadeghi, S; Stein, S | 1 |
Hao, Q; Hu, YL; Liang, YJ; Wang, JD; Wang, QL; Wu, YZ | 1 |
Doyen, J; Ferrero, JM; Fontana, X; Italiano, A; Largillier, R; Thyss, A | 1 |
Apatira, A; Brandt, R; Chang, B; Chua, J; Ding, P; Duan, M; Franci, C; Goff, D; Heckrodt, TJ; Hitoshi, Y; Holland, SJ; Hu, Y; Li, W; Pan, A; Payan, DG; Pine, P; Singh, R; Torneros, A; Yu, J; Zhang, J | 1 |
Beriwal, S; Bhargava, R; Dabbs, DJ; O'Connor, SM | 1 |
Buchanan, SG; Dekoning, T; Eagleson, B; Essenburg, C; Kang, L; Kaufman, D; Staal, B; Su, Y; Vande Woude, GF; West, R; Zhang, YW | 1 |
Cochrane, RA; Davie, MW; Powell, DE | 1 |
Coşkun, U; Oktay, K; Sönmezer, M; Türkçüoğlu, I | 1 |
Anderson, H; Buffa, FM; Detre, S; Dexter, T; Dowsett, M; Dunbier, AK; Ghazoui, Z; Harris, AL; Salter, J; Smith, IE | 1 |
Bagalà, C; Barone, C; Basso, M; Cerchiaro, E; D'Argento, E; Inno, A; Marsico, VA; Vecchio, FM | 1 |
Bedard, PL; Bradbury, I; Desmedt, C; Dixon, JM; Evans, DB; Haibe-Kains, B; Ignatiadis, M; Loi, S; Michiels, S; Miller, WR; Piccart, MJ; Singhal, SK; Sotiriou, C | 1 |
Argonza-Aviles, E; Beck, JT; Bosserman, L; Brufsky, AM; Ericson, SG; Harker, WG; Hohneker, J; Jin, L; Perez, EA; Seidler, C; Vogel, C; Warsi, G | 1 |
Hozumi, Y; Ohashi, Y; Ohsumi, S; Shimozuma, K; Suemasu, K; Takehara, M; Takei, H | 1 |
Amonkar, MM; Diaz, JR; Forbes, CA; Kleijnen, J; Lykopoulos, K; Rea, DW; Riemsma, R | 1 |
Ali, SM; Carney, W; Chaudri-Ross, HA; Demers, L; Evans, D; Hackl, W; Hamer, P; Harvey, HA; Lang, R; Leitzel, K; Lipton, A | 1 |
Boulay, A; Chen, S; Evans, DB; Lane, HA; O'Reilly, T; Rudloff, J; Ye, J; Zumstein-Mecker, S | 1 |
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E | 1 |
Rennie, I; Rundle, P | 1 |
Ali, SM; Carney, W; Chaudri-Ross, HA; Demers, L; Evans, DB; Hackl, W; Hamer, P; Leitzel, K; Lipton, A; Souder, C | 1 |
Abrial, C; Chollet, P; Curé, H; Durando, X; Leheurteur, M; Mouret-Reynier, MA; Tacca, O | 1 |
DiLeonardo, M; Gibbons, G; Resnik, KS | 1 |
Costantino, J; Cronin, W; Geyer, C; Harkins, B; Jeong, JH; Lembersky, B; Mamounas, EP; Paik, S; Wickerham, DL; Wolmark, N | 1 |
Nortier, JW; Seynaeve, C; van de Velde, CJ; van Nes, JG | 1 |
Chishima, T; Ichikawa, Y; Inui, K; Ishikawa, T; Matsumoto, C; Momiyama, N; Shimada, H; Togo, S | 1 |
Bell, R; Lewis, J | 1 |
Detre, S; Dowsett, M; Grimshaw, R; Lee, K; Macaulay, VM; Rowlands, M | 1 |
Buzdar, AU; Jones, SE; Plourde, P; Vogel, CL; Webster, A; Wolter, J | 1 |
Bell, J; Brunetto, VL; Lee, RB; Rose, PG; VanLe, L; Walker, JL | 1 |
Christov, K; Graves, J; Hu, L; Kelloff, G; Lubet, R; Mehta, RR; Shilkaitis, A; Steele, V; You, M | 1 |
Bijnens, L; Michiels, B; Molenberghs, G; Thijs, H; Vangeneugden, T | 1 |
Khare, GP; Robins, RK; Sidwell, RW; Witkowski, JT | 1 |
Tjälve, H | 1 |
Tudhope, GR | 1 |
Pliss, MB; Rubenchik, BL; Shipko, GP | 1 |
6 review(s) available for triazoles and Carcinoma
Article | Year |
---|---|
Targeting HER2 for the treatment of breast cancer.
Topics: Anastrozole; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Humans; Lapatinib; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Trastuzumab; Triazoles | 2015 |
Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy.
Topics: Anastrozole; Androstadienes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Everolimus; Female; Fulvestrant; Humans; Letrozole; Nitriles; Piperazines; Pyridines; Randomized Controlled Trials as Topic; Trastuzumab; Triazoles | 2016 |
Systematic review of lapatinib in combination with letrozole compared with other first-line treatments for hormone receptor positive(HR+) and HER2+ advanced or metastatic breast cancer(MBC).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Disease Progression; Female; Humans; Lapatinib; Letrozole; Neoadjuvant Therapy; Neoplasm Metastasis; Nitriles; Quinazolines; Receptor, ErbB-2; Receptors, Cytoplasmic and Nuclear; Triazoles | 2012 |
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.
Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles | 2005 |
[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].
Topics: Anastrozole; Androstadienes; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Letrozole; Nitriles; Postmenopause; Tamoxifen; Treatment Outcome; Triazoles | 2006 |
The control and biological importance of intratumoural aromatase in breast cancer.
Topics: Adenocarcinoma; Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Male; Mice; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Triazoles; Tumor Cells, Cultured | 1996 |
7 trial(s) available for triazoles and Carcinoma
Article | Year |
---|---|
Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lapatinib; Letrozole; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Postmenopause; Prognosis; Proportional Hazards Models; Quinazolines; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Survival Analysis; Treatment Outcome; Triazoles | 2009 |
Final 5-year results of Z-FAST trial: adjuvant zoledronic acid maintains bone mass in postmenopausal breast cancer patients receiving letrozole.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Letrozole; Middle Aged; Nitriles; Organ Size; Osteoporosis, Postmenopausal; Postmenopause; Triazoles; Zoledronic Acid | 2012 |
Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Depression; Female; Humans; Maintenance Chemotherapy; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Quality of Life; Stress, Psychological; Surveys and Questionnaires; Tamoxifen; Treatment Outcome; Triazoles | 2012 |
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Double-Blind Method; ErbB Receptors; Female; Humans; Letrozole; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Nitriles; Prognosis; Receptor, ErbB-2; Survival Analysis; Tamoxifen; Triazoles | 2006 |
NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-fr
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Letrozole; Neoplasm Staging; Nitriles; Patient Selection; Postmenopause; Tamoxifen; Triazoles | 2006 |
A phase III trial comparing anastrozole (1 and 10 milligrams), a potent and selective aromatase inhibitor, with megestrol acetate in postmenopausal women with advanced breast carcinoma. Arimidex Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Double-Blind Method; Enzyme Inhibitors; Female; Humans; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Pregnanes; Triazoles | 1997 |
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Carcinoma; Drug Administration Schedule; Endometrial Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Triazoles | 2000 |
38 other study(ies) available for triazoles and Carcinoma
Article | Year |
---|---|
Bromuconazole fungicide induces cell cycle arrest and apoptotic cell death in cultured human colon carcinoma cells (HCT116) via oxidative stress process.
Topics: Acetylcysteine; Apoptosis; Biomarkers; Carcinoma; Caspase 3; Cell Cycle Checkpoints; Cell Line, Tumor; Colon; DNA; Fluorescein-5-isothiocyanate; Fungicides, Industrial; Humans; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Triazoles | 2022 |
The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Carcinoma; Female; Humans; Letrozole; Middle Aged; Neoplasm Grading; Neoplasm Staging; Nitriles; Ovarian Neoplasms; Receptors, Estrogen; Recurrence; Retreatment; Retrospective Studies; Tamoxifen; Treatment Outcome; Triazoles; Young Adult | 2017 |
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
Topics: Adolescent; Adult; Aged; Animals; Azepines; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Enhancer Elements, Genetic; Epigenesis, Genetic; Epstein-Barr Virus Infections; ETS Translocation Variant 6 Protein; Female; Genome, Viral; Heterografts; High-Throughput Nucleotide Sequencing; Histone Code; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nuclear Proteins; Prognosis; Proto-Oncogene Proteins c-ets; Repressor Proteins; Transcription Factors; Triazoles; Young Adult | 2017 |
Complex formation, thermal behavior and stability competition between Cu(II) ion and Cu(0) nanoparticles with some new azo dyes. Antioxidant and in vitro cytotoxic activity.
Topics: Animals; Antineoplastic Agents; Antioxidants; Azo Compounds; Benzothiazoles; Carcinoma; Coloring Agents; Coordination Complexes; Copper; Female; Mice; Nanoparticles; Spectrum Analysis; Sulfonic Acids; Thiadiazoles; Triazoles | 2013 |
Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Azocines; Baculoviral IAP Repeat-Containing 3 Protein; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Mice, Nude; Mitochondrial Proteins; Molecular Mimicry; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplastic Stem Cells; TNF-Related Apoptosis-Inducing Ligand; Triazoles; Ubiquitin-Protein Ligases; X-Linked Inhibitor of Apoptosis Protein; Xenograft Model Antitumor Assays | 2013 |
Tardive dyskinesia associated with anastrozole.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Movement Disorders; Nitriles; Triazoles | 2013 |
Inhibiting EGFR dimerization using triazolyl-bridged dimerization arm mimics.
Topics: Allosteric Regulation; Carcinoma; Dimerization; Ectodysplasins; ErbB Receptors; Humans; Models, Molecular; Molecular Dynamics Simulation; Protein Engineering; Triazoles | 2015 |
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
Topics: Animals; Antineoplastic Agents; Azepines; Carcinoma; Cell Line, Tumor; Down-Regulation; Female; Forkhead Box Protein M1; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Ovarian Neoplasms; Pteridines; Transcription Factors; Triazoles | 2016 |
MCM5 as a target of BET inhibitors in thyroid cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Benzodiazepines; Carcinoma; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Mice, Knockout; Neoplasm Proteins; Nuclear Proteins; Thyroid Gland; Thyroid Neoplasms; Triazoles | 2016 |
Implication of the Receptor Tyrosine Kinase AXL in Head and Neck Cancer Progression.
Topics: Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Head and Neck Neoplasms; Humans; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Triazoles | 2016 |
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Hematologic Diseases; Humans; Hypertension; Infusions, Intravenous; Letrozole; Mastectomy; Middle Aged; Nitriles; Paclitaxel; Prognosis; Proteinuria; Radiotherapy, Adjuvant; Triazoles | 2009 |
Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma.
Topics: Aged; Anastrozole; Antineoplastic Agents; Aromatase Inhibitors; Carcinoma; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Endometrium; Female; Humans; Letrozole; Middle Aged; Neoplasm Metastasis; Nitriles; Organ Size; Retrospective Studies; Time Factors; Triazoles | 2009 |
Synthesis and cytotoxic profile of glycosyl-triazole linked to 1,2,4-oxadiazole moiety at C-5 through a straight-chain carbon and oxygen atoms.
Topics: Antineoplastic Agents; Carbon; Carcinoma; Cell Line, Tumor; Cell Proliferation; Glycosylation; Humans; Laryngeal Neoplasms; Lung Neoplasms; Oxadiazoles; Oxygen; Triazoles | 2009 |
Synthesis, structure elucidation and antitumour activity of N-substituted amides of 3-(3-ethylthio-1,2,4-triazol-5-yl)propenoic acid.
Topics: Amides; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Line; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Female; Fibroblasts; Humans; Lung Neoplasms; Skin; Triazoles | 2009 |
A novel variant of ER-alpha, ER-alpha36 mediates testosterone-stimulated ERK and Akt activation in endometrial cancer Hec1A cells.
Topics: Aromatase Inhibitors; Carcinoma; Cell Membrane; Endometrial Neoplasms; Enzyme Activation; Estrogen Receptor alpha; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Letrozole; Nitriles; Phosphorylation; Protein Isoforms; Proto-Oncogene Proteins c-akt; Signal Transduction; Testosterone; Triazoles; Tumor Cells, Cultured | 2009 |
Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Carcinoma; Cell Line, Tumor; Cell Proliferation; Curcumin; Down-Regulation; Drug Synergism; Endometrial Neoplasms; Female; Humans; Letrozole; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Triazoles; Xenograft Model Antitumor Assays | 2009 |
Aromatase inhibition in male breast cancer patients: biological and clinical implications.
Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms, Male; Carcinoma; Estradiol; Humans; Letrozole; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Retrospective Studies; Survival Analysis; Testosterone; Treatment Outcome; Triazoles | 2010 |
R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.
Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Benzocycloheptenes; Breast Neoplasms; Carcinoma; Female; HeLa Cells; Humans; K562 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Oncogene Proteins; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Survival Analysis; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2010 |
Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
Topics: Anastrozole; Anesthetics, Combined; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Early Detection of Cancer; Female; Gonadal Steroid Hormones; Humans; Immunohistochemistry; Neoplasm Recurrence, Local; Nitriles; Practice Guidelines as Topic; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; Tamoxifen; Triazoles | 2010 |
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growth.
Topics: Animals; Carcinoma; Cell Cycle; Cell Growth Processes; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Female; Hepatocyte Growth Factor; Humans; Mice; Mice, Inbred C3H; Mice, SCID; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridazines; Quinazolines; Receptors, Growth Factor; Triazoles; Xenograft Model Antitumor Assays | 2010 |
Does anastrozole affect bone resorption similarly in early and late postmenopausal women?
Topics: Age Factors; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Bone Density; Bone Resorption; Breast Neoplasms; Carcinoma; Case-Control Studies; Collagen Type I; Cross-Sectional Studies; Female; Humans; Middle Aged; Nitriles; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Risk Factors; Triazoles | 2011 |
Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles.
Topics: Adult; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Cryopreservation; Drug Administration Schedule; Emergency Medical Services; Female; Fertility; Humans; Infertility, Female; Letrozole; Menstrual Cycle; Nitriles; Oocyte Retrieval; Oocytes; Ovulation Induction; Preservation, Biological; Time Factors; Triazoles | 2011 |
Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Cell Hypoxia; Cell Proliferation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Nitriles; Predictive Value of Tests; Receptors, Estrogen; Sensitivity and Specificity; Triazoles | 2011 |
Anastrozole-related acute hepatitis with autoimmune features: a case report.
Topics: Acute Disease; Aged; Anastrozole; Antibodies, Antinuclear; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Female; Hepatitis, Autoimmune; Humans; Nitriles; Treatment Outcome; Triazoles | 2011 |
Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Pharmacological; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Cell Proliferation; Cell Survival; Early Detection of Cancer; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Letrozole; Microarray Analysis; Middle Aged; Neoplasm, Residual; Nitriles; Prognosis; Receptors, Estrogen; Time Factors; Triazoles | 2011 |
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapy.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Disease Progression; Estrogen Antagonists; Female; Humans; Letrozole; Nitriles; Prognosis; Receptor, ErbB-2; Survival Analysis; Tamoxifen; Triazoles | 2005 |
Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Cell Proliferation; Cell Survival; Drug Interactions; Estrogens; Everolimus; Female; Humans; Immunosuppressive Agents; Letrozole; Nitriles; Protein Kinases; Receptors, Estrogen; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured | 2005 |
Photodynamic therapy for solitary retinal metastasis from breast carcinoma.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Middle Aged; Nitriles; Photochemotherapy; Retinal Neoplasms; Triazoles | 2006 |
Mammalian target of rapamycin inhibitors in combination with letrozole in breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Letrozole; Nitriles; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Protein Kinases; Sirolimus; TOR Serine-Threonine Kinases; Treatment Outcome; Triazoles | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Capecitabine; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Lobular; Carcinoma, Signet Ring Cell; Deoxycytidine; Estradiol; Facial Neoplasms; Female; Fluorouracil; Fulvestrant; Humans; Incidental Findings; Letrozole; Mastectomy, Radical; Megestrol Acetate; Melanoma; Neoplasms, Second Primary; Neoplastic Cells, Circulating; Nitriles; Selective Estrogen Receptor Modulators; Skin Neoplasms; Tamoxifen; Triazoles; Wound Healing | 2006 |
[A case of advanced breast cancer with multiple liver metastases resistant to chemotherapy responding to high-dose toremifene].
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Middle Aged; Nitriles; Quality of Life; Remission Induction; Toremifene; Triazoles | 2007 |
Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Colles' Fracture; Female; Fractures, Bone; Humans; Middle Aged; Nitriles; Postmenopause; Risk Assessment; Tamoxifen; Triazoles; Wrist Injuries | 2007 |
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis.
Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles | 2000 |
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Longitudinal Studies; Models, Statistical; Neoplasms, Hormone-Dependent; Patient Dropouts; Quality of Life; Triazoles | 2002 |
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides.
Topics: Adenoviridae; Amides; Animals; Antiviral Agents; Carcinoma; Cell Line; Cells, Cultured; Cytopathogenic Effect, Viral; Glycosides; Humans; Influenza, Human; Mice; Nasopharyngeal Neoplasms; Respirovirus; Rhinovirus; Simplexvirus; Triazoles | 1973 |
X-accumulation of labelled aminotriazole in some transplanted tumours in mice.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Carcinoma; Fibrosarcoma; Intestines; Kidney; Liver; Lymphoma; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Time Factors; Transplantation, Homologous; Triazoles | 1974 |
The inhibition of catalase by plasma and by human tissue extracts.
Topics: Ascorbic Acid; Blood; Carcinoma; Catalase; Conductometry; Dialysis; Edetic Acid; Erythrocytes; Ethylmaleimide; Hemolysis; Hot Temperature; Humans; Kidney; Liver; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Stomach Neoplasms; Tissue Extracts; Triazoles | 1969 |
[Water-soluble and lipid-bound catalase in the liver and malignant tumors of rats].
Topics: Animals; Carcinoma; Catalase; Chemical Phenomena; Chemistry, Physical; Depression, Chemical; Lipid Metabolism; Liver; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Solubility; Triazoles | 1966 |